Skip to content

Repetitive transcranial magnetic stimulation on cognition in mild cognitive impairment and early stage of Alzheimer's disease

Repetitive transcranial magnetic stimulation on cognition in mild cognitive impairment and early stage of Alzheimer's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16009063
Enrollment
Unknown
Registered
2016-08-22
Start date
2016-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Interventions

Stimulation Group:rTMS
Control Group:Shan stimulation

Sponsors

Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50-85 years old, no limitation of sex; 2. MCI patients in accordance with the diagnostic criteria for "mild cognitive impairment due to alzheimer's disease" from National Institutes of Health National Institute on Aging-Alzheimer's Association (NIA - AA) (2011), early stage AD patients in accordance with the diagnostic criteria for probable AD from NIA - AA (2011); 3. MCI patients clinical dementia rating (CDR)=0.5, early stage AD patients CDR=1; 4. Hachinski Ischemic Scale (HIS) =7; 5. Able to tolerate fMRI; 6. Participants should have the caregiver stable and reliable, and available to the institution for 10 consecutive working days for treatment; 7. Have the ability to complete tests for cognitive ability.

Exclusion criteria

Exclusion criteria: 1. Other causes of cognitive decline: cerebrovascular disease, central nervous system infection, CJD, huntington's and Parkinson's disease, DLB, traumatic brain dementia, other physical and chemical factors (such as drugs, alcohol, CO), systemic disease (hepatic encephalopathy, pulmonary encephalopathy, etc.), intracranial occupation (a subdural hematoma, brain tumor), the endocrine system disease (thyroid disease, parathyroid disease), and vitamins deficiency or any other causes of dementia; 2. The history of nervous system diseases, including stroke, optic myelitis, Parkinson's disease, epilepsy, etc.); 3. Psychiatric patients, including schizophrenia or other mental illnesses, bipolar disorder, major depression or delirium; 4. Vision or hearing problems that lead to poor performance of cognitive test; 5. Embedded any metal implants (eg. cardiac pacemaker or intravascular stent); 6. The researchers believe that the subjects could not complete the study.

Design outcomes

Primary

MeasureTime frame
Addenbrookes cognitive examination-3;Auditory Verbal Learning Test;Logic memory test;structural MRI, resting-state connectivity and ;

Secondary

MeasureTime frame
Trail making test;Geriatric Depression Scale;Cognitive dysfunction;Activities of daily living;

Countries

China

Contacts

Public ContactWang Gang

Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine

wgneuron@hotmail.com+86 15900616110

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026